60 Degrees Pharmaceuticals Announces 2025 Annual Results
60 Degrees Pharmaceuticals, Inc. announced its 2025 fiscal year results showing a 65% increase in net product revenues to $1 million, improved net loss compared to the previous year, and expanded commercial and clinical initiatives including new partnerships and study enrollments. The company also reported exhaustion of current share offering capac…